Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Uchida (Tokyo, Japan), J. Terada (Chiba, Japan), T. Homma (Tokyo, Japan), R. Honda (Chiba, Japan), H. Saito (Chiba, Japan), H. Sagara (Tokyo, Japan). Looking into real world practice of elder pulmonary non-tuberculous mycobacterial infection.. 2939

Member's Comments

No comment yet.

Related content which might interest you: Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 The prevalence and clinical profile of non-tuberculous mycobacterial pulmonary infection in Singapore Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020 Year: 2021 Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country Source: ERJ Open Res, 5 (4) 00110-2018; 10.1183/23120541.00110-2018 Year: 2019 How important is work as a risk for lung infections? A story of tuberculosis and pneumonia Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working? Year: 2020 TB disease and infection. Do we have real news? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018 Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 The non-tuberculous pulmonary disease experience in a general respiratory clinic in the UK Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Pulmonary infections in HIV-infected patients: an update in the 21st century Source: Eur Respir J 2012; 39: 730-745 Year: 2012 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Mycobacterial species causing pulmonary tuberculosis in a teaching hospital in Ghana Source: Eur Respir J 2005; 26: Suppl. 49, 413s Year: 2005 The prevalence of non-tuberculous mycobacterium pulmonary infection in a tertiary hospital in Singapore Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada Source: Eur Respir J 2011; 37: 1158-1165 Year: 2011